|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
INCREASED SEDATIVE EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
CO-ADMINISTRATION OF DIAZEPAM AS AN ADJUNCT IN TREATING CONVULSIVE DISORDERS RESULTS IN POSSIBILITY OF AN INCREASE IN THE FREQUENCY AND/OR SEVERITY OF GRAND MAL SEIZURES WHICH MAY REQUIRE AN INCREASE IN THE DOSAGE OF STANDARD ANTICONVULSANT AGENT
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
LEVODOPA EFFECT IS REDUCED BY THE DRUG
|
INCREASED SEDATIVE EFFECT
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
INCREASED SEDATIVE EFFECT
|
MEPHENESIN CNS MUSCLE RELAXANT EFFECT IS ENHANCED BY THE DRUG
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
INCREASED SEDATIVE EFFECT
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
INCREASED SEDATIVE EFFECT; BUT RATE OF ORAL ABSORPTION OF DIAZEPAM IS REDUCED
|
INCREASED SEDATIVE EFFECT; BUT RATE OF ORAL ABSORPTION OF DIAZEPAM IS REDUCED
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
INCREASED SEDATIVE EFFECT
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
INCREASED SEDATIVE EFFECT
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
HIV PROTEASE INHIBITORS MAY INCREASE PLASMA CONCENTRATION OF THE DRUG DUE TO INHIBITION OF THEIR METABOLISM
|
ESOMEPRAZOLE INHIBITS GASTRIC ACID SECRETION & MAY INTERFERE WITH THE ABSORPTION OF DRUGS WHERE GASTRIC PH IS AN IMPORTANT DETERMINANT OF BIOAVAILABILITY
|
ESOMEPRAZOLE PROLONGS ELIMINATION OF THE DRUG
|
INCREASED SEDATIVE EFFECT
|
HIV PROTEASE INHIBITORS MAY INCREASE PLASMA CONCENTRATION OF THE DRUG DUE TO INHIBITION OF THEIR METABOLISM
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
GATIFLOXACIN MAY HAVE THE POTENTIAL TO PROLONG THE QT INTERVAL ; CO-ADMINISTRATION WITH DRUGS KNOWN TO PROLONG QT INTERVAL SHOULD BE AVOIDED
|
CO-ADMINISTRATION OF DIAZEPAM AS AN ADJUNCT IN TREATING CONVULSIVE DISORDERS RESULTS IN POSSIBILITY OF AN INCREASE IN THE FREQUENCY AND/OR SEVERITY OF GRAND MAL SEIZURES WHICH MAY REQUIRE AN INCREASE IN THE DOSAGE OF STANDARD ANTICONVULSANT AGENT
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
INCREASED SEDATIVE EFFECT
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
INCREASED SEDATIVE EFFECT
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
INCREASED SEDATIVE EFFECT
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
ERYTHROMYCIN DECREASES CLEARANCE OF BENZODIAZEPINES, THUS INCREASE THE PHARMACOLOGIC EFFECT OF THE DRUG SO THEIR DOSE SHOULD BE REDUCED TO 1/3
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT; BUT RATE OF ORAL ABSORPTION OF DIAZEPAM IS REDUCED
|
BENZODIAZEPINES DOSE IS TO BE INCREASED TO ACHIEVE SEDATION ON CONCOMITANT USE. DOSE SHOULD BE REDUCED ONCE THEOPHYLLINE IS WITHDRAWN OTHERWISE TOXICITY APPEARS
|
INCREASED SEDATIVE EFFECT
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
BENZODIAZEPINES CAN CAUSE RESPIRATORY DEPRESSION BUT DOSE OF BARBITURATE IS DECREASED
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
CO-ADMINISTRATION OF DIAZEPAM AS AN ADJUNCT IN TREATING CONVULSIVE DISORDERS RESULTS IN POSSIBILITY OF AN INCREASE IN THE FREQUENCY AND/OR SEVERITY OF GRAND MAL SEIZURES WHICH MAY REQUIRE AN INCREASE IN THE DOSAGE OF STANDARD ANTICONVULSANT AGENT
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
INCREASED SEDATIVE EFFECT
|
BENZODIAZEPINES DOSE IS TO BE INCREASED TO ACHIEVE SEDATION ON CONCOMITANT USE. DOSE SHOULD BE REDUCED ONCE THEOPHYLLINE IS WITHDRAWN OTHERWISE TOXICITY APPEARS
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
MAY INCREASE DROWSINESS EFFECT
|
INCREASED SEDATIVE EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
INCREASED SEDATIVE EFFECT
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
ISONIAZID REDUCES ALPRAZOLAM & OTHER BENZODIAZEPINES CLEARANCE SO REDUCE ALPRAZOLAM DOSE TO 1/3
|
INCREASED SEDATIVE EFFECT
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|
KETAMINE EFFECT IS PROLONGED WITH SUBSEQUENT DELAY IN RECOVERY DUE TO CONCOMITANT USE
|
BENZODIAZEPINES / DIAZEPAM CLEARANCE IS REDUCED BY CO-ADMINISTRATION; HENCE THE DOSE OF DIAZEPAM IS REDUCED BY ONE THIRD
|